INSP Stock Analysis: Buy, Sell, or Hold?
INSP - Inspire Medical Systems, Inc.
$41.35
-1.26 (-2.96%)
▼
5d:
-3.16%
30d:
-6.32%
90d:
-23.03%
BUY
HIGH Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Aug 03, 2026
Get Alerted When INSP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: INSP appears deeply undervalued. Market expects -4.3% annual earnings decline despite 308% recent earnings growth. Contrarian opportunity at discount to historical valuation.
✅ BUY SIGNAL: INSP appears deeply undervalued. Market expects -4.3% annual earnings decline despite 308% recent earnings growth. Contrarian opportunity at discount to historical valuation.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$63.14
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$39.20
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: INSP is currently trading at $41.35, which is considered slightly low relative to its 30-day fair value range of $40.89 to $43.12. From a valuation perspective, the stock is trading at a discount (Forward PE: 31.9) compared to its historical average (36.4). Remarkably, the market is currently pricing in an annual earnings decline of 4.3% over the next few years. This pessimistic expectation contrasts with the company's recent 308.4% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, INSP is in a strong downtrend. Immediate support is located at $39.73, while resistance sits at $44.53.
Market Sentiment: INSP has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (18th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $52.17 (+26.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, INSP is in a strong downtrend. Immediate support is located at $39.73, while resistance sits at $44.53.
Market Sentiment: INSP has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (18th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $52.17 (+26.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$40.89 -
$43.12
Company Quality Score
61/100
(BUY)
Options IV Signal
18th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
92.3%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 18th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 26.2% below Wall St target ($52.17)
Trading Range Analysis
30-Day Trading Range
$40.89 -
$43.12
Current vs Trading Range
SLIGHTLY LOW
Expected Move (7 Days)
±$4.29
(10.4%)
Support & Resistance Levels
Support Level
$39.73
Resistance Level
$44.53
Current Trend
Strong Downtrend
Technical data as of
Jun 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
31.88
Wall Street Target
$52.17
(+26.2%)
Revenue Growth (YoY)
1.6%
Earnings Growth (YoY)
308.4%
Profit Margin
14.3%
Valuation Discount vs History
-4.3% cheaper
PE vs Historical
31.9 vs 36.4
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-4.3%
(market-implied from PE analysis)
1-Year Target
$39.57
(-4%)
2-Year Target
$37.87
(-8%)
3-Year Target
$36.24
(-12%)
3-Yr Target (if PE normalizes)
(PE: 32→36)
$41.38
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 31.9, Growth: 44.3%)
$124.22
(+200%)
Base:
(SPY PE: 21.8, Growth: 44.3%)
$84.86
(+105%)
Bear:
(PE: 18.5, Growth: 44.3%)
$72.13
(+74%)
📈
Valuation based on Current Earnings
Trailing PE: 9.68 | Current EPS (TTM): $4.40
Bull Case
$23.44
(-43%)
Analyst growth -50.0%, PE expands to 10.7
Base Case
$21.31
(-49%)
Market implied -50.0%, PE stable at 9.7
Bear Case
$28.97
(-30%)
Severe decline -20.0%, PE contracts to 8.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 31.9 to 36.4
Stabilization Target:
$47.21
(+14.2%)
PE Expansion Potential:
+14.2%
Share & Embed Analysis
Last updated: June 23, 2026 2:22 AM ET
Data refreshes hourly during market hours. Next update: 3:22 AM
Data refreshes hourly during market hours. Next update: 3:22 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INSP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
John Rondoni
SELL
109 shares
2026-01-09
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$77 | 52 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 57 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 61 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$242 | 60 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 63 BUY |
Advanced INSP Option Strategies
Professional options setups generated by AI based on today's INSP price and gamma walls.
